Prescient Therapeutics Limited announced that Mr. Steven Yatomi-Clarke has advised the Board that he will step down as Chief Executive Officer of Prescient to pursue a new appointment. Mr. Yatomi-Clarke intends to remain in his position until the end of February 2025, and while the Company conducts a search for a new CEO. The Board of Prescient will conduct a search for a new CEO to continue the Company's momentum.

If required, Mr. Engle, will act as Executive Chair until the appointment of the new CEO. Following the appointment of his successor, Mr. Yatomi-Clarke has agreed to remain available as a consultant to Prescient to provide ongoing assistance to the Company.